Improvement in Cognition by α7 Nicotinic Acetylcholine Receptor Partial Agonist APN1125 in Preclinical Models as a Prologue to Clinical Development

被引：0
|
作者：
Detke, Michael J. [1 ,2 ]
Stevens, Karen E. [3 ]
Koelsch, Gerald [4 ]
Anderson, Paul C. [4 ]
Meltzer, Leonard T. [5 ]
Yoshimura, Ryan F. [6 ]
Bilcer, Geoffrey [7 ]
Ng, John [8 ]
Ng, Raymond [8 ]
Gee, Kelvin W. [6 ]
Kelly, Terence A. [7 ]
机构：
[1] CoMentis, Clin, San Francisco, CA USA
[2] Indiana Univ, San Francisco, CA USA
[3] Univ Colorado, Psychiat, Denver, CO 80202 USA
[4] CoMentis & Alpharmagen, Biol, San Francisco, CA USA
[5] L Meltzer CNS Consulting, Biol, Ann Arbor, MI USA
[6] Alpharmagen & Anvyl, Biol, San Francisco, CA USA
[7] CoMentis & Alpharmagen, Chem, San Francisco, CA USA
[8] CoMentis & Alpharmagen, CMC, San Francisco, CA USA
来源：
BIOLOGICAL PSYCHIATRY | 2015年 / 77卷 / 09期
关键词：
nicotinic; cognition; schizophrenia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
738
引用
收藏
页数：1
相关论文
共 42 条
  • [21] Mecamylamine reversal by nicotine and by a partial α7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning
    Woodruff-Pak, DS
    BEHAVIOURAL BRAIN RESEARCH, 2003, 143 (02) : 159 - 167
  • [22] Optimization of Novel α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulators and the Discovery of a Preclinical Development Candidate Molecule (RGH-560)
    Ledneczki, Istvan
    Nemethy, Zsolt
    Molnar, Katalin Dudasne
    Tapolcsanyi, Pal
    Ilkei, Viktor
    Vago, Istvan
    Kolok, Sandor
    Than, Marta
    Laszy, Judit
    Balazs, Ottilia
    Kramos, Balazs
    Szigetvari, Aron
    Bata, Imre
    Mako, Attila
    Visegrady, Andras
    Fodor, Laszlo
    Vastag, Monika
    Levay, Gyorgy
    Lendvai, Balazs
    Greiner, Istvan
    Eles, Janos
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 16276 - 16302
  • [23] α 7 RECEPTOR PRIMING MODULATES NEURONAL FIRING AND THETA RHYTHMS: A PUTATIVE MECHANISM FOR ENHANCED COGNITION IN CLINICAL AND PRECLINICAL MODELS
    Koenig, Gerhard
    Townsend, Mathew
    Flood, Dorothy
    Piser, Timothy
    Tang, Cuyue
    Hajos, Mihaly
    Stoikilovic, Milan
    Leventhal, Liza
    Chen, Ting
    Lombardo, Ilise
    Hilt, Dana
    Stahl, Stephen
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S84 - S84
  • [24] Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models
    Park, Jung-Eun
    Leem, Yea-Hyun
    Park, Jin-Sun
    Kim, Do-Yeon
    Kang, Jihee Lee
    Kim, Hee-Sun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [25] In vitro pharmacological characterization and pro-cognitive effects of the novel alpha-7 nicotinic acetylcholine receptor partial agonist, SKL-A4R
    Maeng, C. Y.
    Joung, C. M.
    Shin, H. W.
    Jang, Y. K.
    Cha, S. B.
    Cha, H. R.
    Yi, E. J.
    Park, C. H.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 1040 - 1040
  • [26] The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release
    Mei Huang
    Anna R Felix
    Sunoh Kwon
    David Lowe
    Tanya Wallace
    Luca Santarelli
    Herbert Y Meltzer
    Psychopharmacology, 2014, 231 : 2199 - 2210
  • [27] The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release
    Huang, Mei
    Felix, Anna R.
    Kwon, Sunoh
    Lowe, David
    Wallace, Tanya
    Santarelli, Luca
    Meltzer, Herbert Y.
    PSYCHOPHARMACOLOGY, 2014, 231 (10) : 2199 - 2210
  • [28] Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
    Marquis, Karen L.
    Comery, Thomas A.
    Jow, Flora
    Navarra, Rachel L.
    Grauer, Steven M.
    Pulicicchio, Claudine
    Kelley, Cody
    Brennan, Julie A.
    Roncarati, Renza
    Scali, Carla
    Haydar, Simon
    Ghiron, Chiara
    Terstappen, Georg C.
    Dunlop, John
    PSYCHOPHARMACOLOGY, 2011, 218 (04) : 635 - 647
  • [29] Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
    Karen L. Marquis
    Thomas A. Comery
    Flora Jow
    Rachel L. Navarra
    Steven M. Grauer
    Claudine Pulicicchio
    Cody Kelley
    Julie A. Brennan
    Renza Roncarati
    Carla Scali
    Simon Haydar
    Chiara Ghiron
    Georg C. Terstappen
    John Dunlop
    Psychopharmacology, 2011, 218 : 635 - 647
  • [30] LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization
    Verma, Mahip K.
    Goel, Rajan N.
    Bokare, Anand M.
    Dandekar, Manoj P.
    Koul, Sarita
    Desai, Sagar
    Tota, Santoshkumar
    Singh, Nilendra
    Nigade, Prashant B.
    Patil, Vinod B.
    Modi, Dipak
    Mehta, Maneesh
    Gundu, Jayasagar
    Walunj, Sameer S.
    Karche, Navnath P.
    Sinha, Neelima
    Kamboj, Rajender K.
    Palle, Venkata P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 891
12345